Sign in

Csaba Pal Laboratory

@csabapallab.bsky.social
295 followers 389 following 35 posts

Csaba Pal Lab's interest includes antibiotic resistance research, systems biology, and microbial experimental evolution. Account run by lab members. Szeged, Hungary group.szbk.u-szeged.hu/sysbiol/pal-…

PostsRepliesMedia
Csaba Pal Laboratory @csabapallab.bsky.social · 06/10/2026
📢 Paper Alert! Grateful to have been involved in this amazing work by @thelazarlab.bsky.social and SzilviaJuhasz labs, presenting a framework for dissecting pathogen-host-drug interactions. #Pathogen #Virulence #SingleCell #DeepLearning Check it at: shorturl.at/LQUFP 🧵👇
nature.com
Deep-learning single-cell profiling uncovers interbacterial and drug-driven reshaping of pathogen virulence - Nature Communications
This study introduces MALVINA, a deep-learning platform that measures bacterial invasion and DNA damage in individual human cells, revealing how bacterial interactions and commonly used drugs reshape ...
030
Csaba Pal Laboratory @csabapallab.bsky.social · 04/10/2026
It was also a pleasure to exchange ideas with Emily White from @natmicrobiol.nature.com and Kevin Foster from Oxford, followed by a visit to Isabel Gordo @isabelgordo.bsky.social and her lab after the conference. 🔬 Thank you for a fantastic scientific experience, #GIMMFest2026! 💙
040
Csaba Pal Laboratory @csabapallab.bsky.social · 04/10/2026
What a GIMM Fest! 🧬 @marczikkely.bsky.social, @lejladaruka.bsky.social, and @petraszili.bsky.social presented their research in the poster sessions, with Petra also taking the stage as a Micro Talk speaker. We came away with plenty of new ideas from an inspiring programme of talks and discussions.
240
Csaba Pal Laboratory @csabapallab.bsky.social · 16/06/2026
#mevoSky
000
Csaba Pal Laboratory @csabapallab.bsky.social · 16/06/2026
Can #gene-loss fuel future #adaptation? Check out this exciting new study from @balazs-papp-lab.bsky.social showing that #compensatory-evolution can generate unexpected metabolic gains. Delighted to have contributed! Congratulations to everyone involved! 👏
172
Csaba Pal Laboratory @csabapallab.bsky.social · 10/04/2026
See the original study in @natcomms.nature.com : nature.com/articles/s41.... For more context, see the original thread here: bsky.app/profile/csab...
nature.com
Exploring the principles behind antibiotics with limited resistance - Nature Communications
This study shows that only those dual-targeting antibiotics limit resistance in Gram-negative pathogens that also target the membrane of the bacteria. This mechanism provides a basis for designing future antibiotics with reduced resistance potential.
010
Csaba Pal Laboratory @csabapallab.bsky.social · 10/04/2026
Target type is critical: antibiotics that disrupt membrane integrity while blocking a second essential pathway show markedly reduced resistance evolution in #GramNegative pathogens. #AMR
100
Csaba Pal Laboratory @csabapallab.bsky.social · 10/04/2026
Elvin’s research at the Biological Research Centre (Szeged, Hungary) tackles a central challenge in medicine: how to design effective drugs that #pathogenic bacteria struggle to resist. The key result: #DualTargeting alone is not sufficient.
100
Csaba Pal Laboratory @csabapallab.bsky.social · 10/04/2026
🎓 Warm congrats to Elvin Maharramov @m-elvin.bsky.social on a successful PhD defense on the principles of designing #antibiotics with limited #resistance. A timely and elegant contribution to the field of #DrugDevelopment on how to design less resistance-prone antibiotics. More info below👇
241
Csaba Pal Laboratory @csabapallab.bsky.social · 05/02/2026
Excited to share our collaborative work led by the Szilvia Juhasz and Mate Manczinger @matemanc.bsky.social labs: #cancer mutations converge into five protein-level “fingerprints” that shape tumor immune visibility. Mutation burden alone fails to predict #immunotherapy response! @molsystbiol.org
032
Reposted by Csaba Pal Laboratory
Waggoner Lab @labwaggoner.bsky.social · 19/11/2025
C > U mutations generate immunogenic peptides in SARS-CoV-2 @natcomms.nature.com @matemanc.bsky.social @csabapallab.bsky.social www.nature.com/articles/s41...
133
Reposted by Csaba Pal Laboratory
Máté Manczinger @matemanc.bsky.social · 01/12/2025
C > U mutations generate immunogenic peptides in SARS-CoV-2 APOBEC enzymes—key players of the innate immune system—induce mutations that become fixed in viral genomes and enhance immune recognition. nature.com/articles/s41... #COVID_19 #Immunology #virus #infectiousdiseases #vaccine #Genetics
nature.com
C > U mutations generate immunogenic peptides in SARS-CoV-2 - Nature Communications
The effect of new viral mutations on T cell responses remains unclear. Here, Balogh et al. show that most new mutations in SARS-CoV-2 are C > U, a bias that leads to an enhanced T cell re...
032
Reposted by Csaba Pal Laboratory
Science X / Phys.org @sciencex.bsky.social · 03/03/2025
A dual-target antibiotic strategy, combining membrane disruption with another cellular pathway, shows promise in reducing bacterial resistance, offering a new direction in combating antimicrobial resistance. doi.org/g855sh
phys.org
Study uncovers the core principles of low-resistance antibiotics
A study published in Nature Communications has revealed novel insights into bacterial resistance and offers a promising strategy for developing antibiotics that minimize the evolution of resistance.
064
Reposted by Csaba Pal Laboratory
Christian Landry @christianlandry.bsky.social · 23/02/2025
We are looking for a postdoc in #EvolutionarySystemsBiology. Exciting science, amazing team, wonderful city! landrylab.ibis.ulaval.ca/research-opp... #evolution #synbio #systemsbiology #genomics
landrylab.ibis.ulaval.ca
Research opportunities | Landry Lab
06774
Csaba Pal Laboratory @csabapallab.bsky.social · 24/02/2025
For previous research on #FutureAntibiotics and resistance development see our recent publications here: tinyurl.com/2cbyrx55 and tinyurl.com/2mxaz5a6 #MEvoSky
030
Csaba Pal Laboratory @csabapallab.bsky.social · 24/02/2025
5/5 - Contributors: This work was spearheaded by @m-elvin.bsky.social and @marczikkely.bsky.social at HUN-REN Biological Research Centre, Szeged
110
Csaba Pal Laboratory @csabapallab.bsky.social · 24/02/2025
4/5 - Implications for the Future: These insights provide a blueprint for developing next-gen antibiotics ( #FutureAntibiotics) designed to stay one step ahead of bacterial defenses. It’s a promising direction in the fight against #AntibioticResistance #AMR.
100
Csaba Pal Laboratory @csabapallab.bsky.social · 24/02/2025
3/5 - A stark contrast: Dual-target topoisomerase antibiotics, despite having two intracellular targets, were more prone to resistance. This highlights that which targets matter just as much as how many. #DrugDevelopment
110
Csaba Pal Laboratory @csabapallab.bsky.social · 24/02/2025
2/5 – Dual target permeabilizers: We tested three promising #DrugCandidates – POL7306, Tridecaptin M152-P3, and SCH79797 – against tough #ESKAPE pathogens like E. coli, K. pneumoniae, A. baumannii, and P. aeruginosa. The results? #ResistanceEvolution was significantly limited.
100
Csaba Pal Laboratory @csabapallab.bsky.social · 24/02/2025
1/5 - The strategy: By combining membrane disruption with another key cellular pathway, we can dramatically limit bacterial #resistance. This “double whammy” makes it much harder for bacteria to fight back. #RationalDesign #Antibiotics
110
Csaba Pal Laboratory @csabapallab.bsky.social · 24/02/2025
🚨 Our latest research in @naturecomms.bsky.social shows a promising strategy for less resistance-prone #antibiotics. For details, see the thread below and read the paper “Exploring the principles behind antibiotics with limited resistance” here: #MEvoSky www.nature.com/articles/s41...
nature.com
Exploring the principles behind antibiotics with limited resistance - Nature Communications
This study shows that only those dual-targeting antibiotics limit resistance in Gram-negative pathogens that also target the membrane of the bacteria. This mechanism provides a basis for designing fut...
13815
Reposted by Csaba Pal Laboratory
Healthcare in Europe @healthcare-europe.bsky.social · 03/02/2025
Two recent studies led by 🇭🇺 @csabapallab.bsky.social find that resistance can develop against new 💊 antibiotics even before they are widely used, compromising their effectiveness from the start. #antibioticresistance #AMR
dlvr.it
New antibiotics can develop resistance before even hitting the market
Researchers from the HUN-REN Biological Research Centre, Szeged (Hungary), have made a concerning discovery about the future of antibiotics.
011
Reposted by Csaba Pal Laboratory
Greg Medlock @gregmedlock.bsky.social · 27/01/2025
Alternative drug modalities/approaches are desperately needed to supplement the pipeline of antibiotics.
153
Reposted by Csaba Pal Laboratory
balazs-papp-lab.bsky.social @balazs-papp-lab.bsky.social · 14/01/2025
ESKAPE pathogens are outsmarting us. Our latest paper in @naturemicrobiol.bsky.social reveals alarming ease of resistance evolution to antibiotics in development. Collaborative work with @csabapallab.bsky.social‬ and Kintses Lab
0137
Reposted by Csaba Pal Laboratory
Nature Microbiology @natmicrobiol.nature.com · 13/01/2025
💊🦠OUT NOW - comprehensive analysis of the propensity of ESKAPE pathogens to evolve resistance to new and in development antibiotics by Csaba Pal, Balint Kintses, Balazs Papp and colleagues. Dive in here... www.nature.com/articles/s41...
nature.com
ESKAPE pathogens rapidly develop resistance against antibiotics in development in vitro - Nature Microbiology
An extensive experimental analysis of resistance to antibiotics in development or introduced post-2017 in ESKAPE bacteria reveals the dynamics of resistance acquisition, mutational targets and the pre...
14022
Csaba Pal Laboratory @csabapallab.bsky.social · 13/01/2025
For a similar study on Gram-positive bacteria, check out our previous thread: bsky.app/profile/csab...
041
Csaba Pal Laboratory @csabapallab.bsky.social · 13/01/2025
7/7 🔗 This study spearheaded by @lejladaruka.bsky.social, @marczikkely.bsky.social, @petraszili.bsky.social and @zoltanfarkas81.bsky.social at Biological Research Centre, Szeged. Important contributions from our long-term collaborators @balazs-papp-lab.bsky.social and Balint Kintses Lab.
120
Csaba Pal Laboratory @csabapallab.bsky.social · 13/01/2025
6/7 📢 Stay tuned! Our upcoming study will reveal a promising strategy to develop less resistance-prone antibiotics! #DrugDevelopment
110
Csaba Pal Laboratory @csabapallab.bsky.social · 13/01/2025
5/7 🔬 The study suggests that certain bacteria were less prone to develop resistance against some of the tested antibiotics, highlighting the potential in narrow-spectrum therapeutics. This presents hope for more effective future treatments. #Antibiotics #PublicHealth
110
Csaba Pal Laboratory @csabapallab.bsky.social · 13/01/2025
4/7 🌍 Functional metagenomics revealed that mobile resistance genes exist not only in clinical isolates but also in the soil and even the human gut microbiome. Resistance is EVERYWHERE, making it harder to tackle with new treatments. #GlobalHealth
120
Csaba Pal Laboratory @csabapallab.bsky.social · 13/01/2025
3/7 🧬 Even more worrying: resistance mutations were already present in natural bacterial populations. This means that some bacteria may already have the arsenal to resist future antibiotics they have never encountered. #EvolutionOfResistance
110
Csaba Pal Laboratory @csabapallab.bsky.social · 13/01/2025
2/7 🦠 We tested 13 new antibiotics (some on the market for a couple of years, others still in development) against 4 of the most critical Gram-negative pathogens. The result? Resistance emerged in just 60 days. This shows how quickly bacteria can adapt! #AntibioticResistance
110
Csaba Pal Laboratory @csabapallab.bsky.social · 13/01/2025
1/7 The rise of drug-resistant infections is a global crisis, but many pharma companies have abandoned antibiotic R&D. While some new drugs are in development, our study shows resistance is emerging rapidly, even to these #FutureAntibiotics. Let’s unpack the results.⬇️
120
Csaba Pal Laboratory @csabapallab.bsky.social · 13/01/2025
🚨 Excited to share that our new study, “ESKAPE pathogens rapidly develop resistance against antibiotics in development in vitro” is published in @naturemicrobiol.bsky.social. For details, see the 🧵below and read the paper here: www.nature.com/articles/s41...
nature.com
ESKAPE pathogens rapidly develop resistance against antibiotics in development in vitro - Nature Microbiology
An extensive experimental analysis of resistance to antibiotics in development or introduced post-2017 in ESKAPE bacteria reveals the dynamics of resistance acquisition, mutational targets and the pre...
13817
Csaba Pal Laboratory @csabapallab.bsky.social · 13/01/2025
Awesome! Many thanks ‪@thealexknapp.bsky.social‬ for spotlighting our recent work!
020
Reposted by Csaba Pal Laboratory
Csaba Pal Laboratory @csabapallab.bsky.social · 13/01/2025
Thrilled to share our latest work, "Antibiotic candidates for Gram-positive bacterial infections induce multidrug resistance" in Science Translational Medicine! For details, see the thread below and read the paper here: www.science.org/doi/10.1126/...
science.org
Antibiotic candidates for Gram-positive bacterial infections induce multidrug resistance
Antibiotic candidates induce multidrug resistance in Staphylococcus aureus without compromising bacterial viability.
11910
Csaba Pal Laboratory @csabapallab.bsky.social · 13/01/2025
This work was spearheaded by Ana Martins, Fanni Judak and @zoltanfarkas81.bsky.social at Biological Research Centre, Szeged. Stay tuned for upcoming updates on #FutureAntibiotics - some exciting stuff on the horizon.
000
Csaba Pal Laboratory @csabapallab.bsky.social · 13/01/2025
Based on our findings, early drug development must prioritize understanding resistance evolution at early stages. Additionally, R&D should focus on creating drug compounds with truly novel designs that actively minimize resistance development. 6/6
100
Csaba Pal Laboratory @csabapallab.bsky.social · 13/01/2025
Key lab-observed resistance mutations already exist in natural bacterial populations. Decades of traditional antibiotic use might have selected for these variants, undermining the long-term efficacy of new drugs even before market introduction. #DrugDevelopment 5/n
100
Csaba Pal Laboratory @csabapallab.bsky.social · 13/01/2025
We discovered overlapping resistance mechanisms: mutations in regulatory systems linked teixobactin resistance to patterns seen with vancomycin and daptomycin. This underscores the interconnected evolution of resistance, complicating efforts to combat #AMR. 4/n
110
Csaba Pal Laboratory @csabapallab.bsky.social · 13/01/2025
Resistant S. aureus strains also developed multi-drug resistance to #teixobactin & stayed virulent in an invertebrate infection model. These bacteria could thrive clinically - alarming for future #therapies. 3/n
110
Csaba Pal Laboratory @csabapallab.bsky.social · 13/01/2025
With the exception of a repurposed drug (SCH79797), S. aureus rapidly developed #resistance to promising candidates, even showing cross-resistance to antibiotics already in clinical use. This complicates treatment strategies. 2/n
100
Csaba Pal Laboratory @csabapallab.bsky.social · 13/01/2025
In this work, we reveal how #Staphylococcus aureus evolves resistance to novel Gram-positive antibiotics - highlighting urgent challenges for early drug development. 1/n
100
Csaba Pal Laboratory @csabapallab.bsky.social · 13/01/2025
Thrilled to share our latest work, "Antibiotic candidates for Gram-positive bacterial infections induce multidrug resistance" in Science Translational Medicine! For details, see the thread below and read the paper here: www.science.org/doi/10.1126/...
science.org
Antibiotic candidates for Gram-positive bacterial infections induce multidrug resistance
Antibiotic candidates induce multidrug resistance in Staphylococcus aureus without compromising bacterial viability.
11910
Reposted by Csaba Pal Laboratory
Christian Landry @christianlandry.bsky.social · 09/01/2025
While writing papers and grants, we received many comments on the role of CNVs in antifungal resistance. We thought we should formally assess how important they are. Here is what we found. #AMR #fungi #evolution rdcu.be/d5rbN
nature.com
The role of gene copy number variation in antimicrobial resistance in human fungal pathogens
npj Antimicrobials and Resistance - The role of gene copy number variation in antimicrobial resistance in human fungal pathogens
12010